Picture of Sinopharm Co logo

1099 Sinopharm Co Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual income statement for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue344,526425,273456,415521,051552,148
Cost of Revenue
Gross Profit31,22837,53140,32344,05147,434
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses329,129409,250438,788501,949531,605
Operating Profit15,39716,02317,62619,10320,543
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes12,20813,76015,59817,00318,564
Provision for Income Taxes
Net Income After Taxes9,40410,62012,09713,06514,345
Minority Interest
Net Income Before Extraordinary Items
Net Income5,8366,2537,1877,7598,526
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income5,8346,2517,1877,7598,526
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.052.132.332.622.74
Dividends per Share